Mednet Logo
HomeNeurologyQuestion

When do you stop dantrolene in a patient with neuroleptic malignant syndrome?

1 Answers
Mednet Member
Mednet Member
Neurology · Baylor College of Medicine

Dantrolene is typically used to treat severe NMS, although the data supporting its use is mixed. The biggest risk with the therapy is hepatotoxicity. It is reasonable to discontinue dantrolene once the hyperthermia and severe muscle rigidity have resolved, or earlier if there is concern for liver in...

Register or Sign In to see full answer

When do you stop dantrolene in a patient with neuroleptic malignant syndrome? | Mednet